This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Colgate's (CL) Innovation & Pricing Efforts Aid: Apt to Buy?
by Zacks Equity Research
Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Tyson Foods' (TSN) Latest Deal Likely to Optimize Plant Network
by Zacks Equity Research
Tyson Foods (TSN) inks a deal to divest its Vienna, GA, poultry complex to House of Raeford Farms. This is likely to help the company optimize the plant network and enhance operations.
Clorox's (CLX) Pricing & Cost Saving on Track: Apt to Hold?
by Zacks Equity Research
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Nu Skin (NUS) Navigates a Tough Landscape on Growth Strategies
by Zacks Equity Research
Nu Skin (NUS) has been dealing with challenges related to customer and affiliate acquisition. However, product launches, technological advancements and strength in the Rhyz business bode well.
Keurig Dr Pepper's (KDP) Brands & Pricing Aid: Apt to Hold?
by Zacks Equity Research
Keurig Dr Pepper (KDP) gains from brand strength, significant pricing actions and a solid performance in its Refreshment Beverages segment.
COTY Benefits From Focus on Growth Pillars Amid Cost Woes
by Zacks Equity Research
COTY benefits from a focus on strategic growth pillars and strong partnerships. However, challenges from a high-cost operating environment are a concern.
Constellation Brands (STZ) Rises on Q1 Earnings Beat, Solid View
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results reflect continued volume growth in the beer business and gains from improved operating margin expansion.
Foodservice Demand Aids Hormel Foods (HRL), High Costs Ail
by Zacks Equity Research
Hormel Foods (HRL) is capitalizing on the increasing demand for Foodservice products. However, rising selling, general and administrative (SG&A) expenses are a deterrent.
Mondelez (MDLZ) Navigates Hurdles Through Portfolio Strength
by Zacks Equity Research
Mondelez's (MDLZ) focus on core categories and portfolio strength place it well in a challenging and dynamic operating environment.
Altria (MO) Up 11% in 3 Months: Is There More Room for Growth?
by Zacks Equity Research
Altria (MO) is benefiting from its focus on expanding smoke-free alternatives and strong pricing power amid low cigarette volumes.
Estee Lauder (EL) on Track With Profit Recovery Amid Hurdles
by Zacks Equity Research
Estee Lauder (EL) is on track to operationalize the Profit Recovery Plan to focus on rebuilding stronger and more sustainable profitability alongside supporting sales growth.
Church & Dwight (CHD) Benefits From Robust Pricing & Brands
by Zacks Equity Research
Church & Dwight (CHD) is resorting to incremental pricing across its portfolio to counter rising costs. Also, it is capitalizing on strong consumer demand for its brands.
Inter Parfums (IPAR) Benefits from Solid Brands Amid High Cost
by Zacks Equity Research
Inter Parfums (IPAR) is benefiting from continued momentum in the fragrance market and successful product launches.
Philip Morris (PM) Gains From Smoke-Free Focus, Key Priorities
by Zacks Equity Research
Robust pricing, strength in smoke-free products and solid cost initiatives work well for Philip Morris (PM) amid elevated costs and volatile currency movements.
United Natural (UNFI) Benefits From Transformation Efforts
by Zacks Equity Research
United Natural (UNFI) embarks on a transformation journey, which includes expanding and intensifying network optimization efforts as well as optimizing cost structures.
Monster Beverage's (MNST) Strategies Seem Prudent: Apt to Hold
by Zacks Equity Research
Monster Beverage (MNST) sees strength in its energy drinks category. In addition, the company's expansion strategy bodes well.
McCormick (MKC) Q2 Earnings Top Estimates, Volumes Down
by Zacks Equity Research
McCormick's (MKC) second-quarter earnings reflect gains from strong brands and a focus on high-growth areas. However, lower volumes acted as a deterrent.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
Colgate's (CL) Strategic Efforts Seem Prudent: Apt to Hold?
by Zacks Equity Research
Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Can Molson Coors' (TAP) Revitalization Plan Aid Amid Cost Woes?
by Zacks Equity Research
Molson Coors' (TAP) Revitalization plan, premiumization efforts and cost-saving plan place it well for long-term growth amid rising costs due to inflationary woes.
Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXG
Strong Brands Aid Helen of Troy (HELE), Macro Headwinds Hurt
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Persistent inflation and rising interest rates are prompting cautious spending behavior.
Energizer's (ENR) Debt Reduction Aids Amid Soft Battery Unit
by Zacks Equity Research
Energizer (ENR) excels in financial strength and strategic growth, reducing debt and boosting profitability, positioning itself as a stable investment with promising prospects.
Altria's (MO) Smoke-Free Growth Underway With Latest FDA Nod
by Zacks Equity Research
Altria's (MO) NJOY obtains authorization from the U.S. Food and Drug Administration for menthol e-vapor products.
Beat the Market Like Zacks: Freshpet, AudioEye, Walmart in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.